SPI Infoamtion

1. Analyst View

2. US Stem Cell Market Overview
　　　2.1 Understanding Stem Cell
　　　2.2 Stem Cell Market

3. US Stem Cell Market Structure
　　　3.1 By Technology
　　　　　　3.1.1 Therapeutic Banking
　　　　　　3.1.2 Cellular Therapeutics
　　　3.2 By Product
　　　　　　3.2.1 Adult Stem Cell
　　　　　　3.2.2 Embryonic Stem Cell

4. Emerging Areas for Therapeutic Applications
　　　4.1 Spinal Cord Injury
　　　4.2 Biologicals and Associated Hardware
　　　4.3 Myocardial Infarction
　　　4.4 Limb Ischemia

5. Key Market Trends
　　　5.1 Cord Blood Banking Market
　　　5.2 Potential Patient Population
　　　5.3 Costly Treatments
　　　5.4 Regenerative Medicines
　　　5.5 Need for Universal Allogenic Treatments

6. Government Regulations and Initiatives

7. Key Players
　　　7.1 StemCells Inc.
　　　7.2 Aastrom Biosciences Inc
　　　7.3 BrainStorm Cell Therapeutics
　　　7.4 ThermoGenesis Corp

List of Figures:
Figure 2-1: Stem Cell Therapy Development Process
Figure 2-2: Stem Cell Market (Million US$), 2008-2012
Figure 2-3: Forecast for Stem Cell Market by Region (%), 2012
Figure 3-1: Therapeutic Banking Market (Million US$), 2007-2012
Figure 3-2: Cellular Therapeutics Market (Million US$), 2007-2012
Figure 3-3: Stem Cell Product Sales (Million US$), 2007-2012
Figure 3-4: Adult Stem Cell Product Market (Million US$), 2008-2012
Figure 4-1: Patients Suffering from Spinal Cord Injury (Million), 2006, 2008 & 2009
Figure 4-2: Patients Suffering from Myocardial Infarction (Million), 2006 & 2008
Figure 5-1: Cord Blood Bank Market (Million US$), 2007 & 2010
Figure 5-2: Share of US in Global Cord Blood Bank Market (2007)
Figure 5-3: Cord Blood Inventory in Public and Private Banks (Million), H1 2008
Figure 5-4: Cord Blood Inventory in Public Banks by Place (Million), H1 2008

List of Tables:
Table 4-1: Stem Cell Therapy Market Potential in Spinal Cord Injury (2009)
Table 5-1: Potential Patient Population for Stem Cell Therapy by Medical Condition (Million)
Table 5-2: Annual Direct Expenditures for Selected Diseases (Billion US$)
Table 5-3: Stem Cell Therapy Cost Comparison to Leading Treatment (Million US$)
Table 6-1: Funding of Stem Cell Research in Different States (2004-2007)
Table 7-1: Stem Cells Inc. - Strengths and Weaknesses
Table 7-2: Aastrom Biosciences Inc - Strengths and Weaknesses
Table 7-3: Brainstorm Cell Therapeutics - Strengths and Weaknesses
Table 7-4: Thermogenesis Corp - Strengths and Weaknesses